Please assess the completion status of the following clinical trial:

Trial Title: A Clinical Trial to Study the Effects of Two Drugs, Lycopene and Prednisolone in Patients With Oral Lichen Planus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subject had symptomatic i.e. burning sensation and/or pain secondary to oral lichen planus.~* Subject had clinically \& histo-pathologically diagnosed as oral lichen planus.~* Subject had not on any treatment for the same or treatment likely to modify their oral lichen planus (e.g. systemic steroids, antifungals, immunosuppressant's, anti-oxidant).~Exclusion Criteria:~* Suffering from any systemic disease/s such as diabetes, hypertension, cardiovascular, respiratory system disease, renal dysfunction, liver disorders, malignancy, active peptic ulcer diseases, acute gastrointestinal diseases, anemia and glaucoma, etc.~* Suffering from serious or recurrent infection, immunodeficiency or HIV.~* Pregnant or breast feeding (including women who wish to be pregnant during the study period).~* Any other mucosal diseases or any other skin diseases which might be associated with oral lesions.~* On any drug therapy which might be causes lichen planus like lesions.~* Known allergy or contraindication to study medications.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- lycopene group (Type: EXPERIMENTAL): Lycopene- 4 mg capsule by mouth single dose per day for 2 months
- Prednisolone group (Type: ACTIVE_COMPARATOR): Prednisolone- 40 mg capsule by mouth single dose per day for 2 months

Based on this trial design, predict the completion outcome and termination type (if applicable).